Johnson & Johnson
Why change management is necessary in the pharmaceutical industry
November 23 by Pharma IQNadine De Decker, Director of Strategic Business Improvement at Johnson & Johnson, explains why change management is necessary in pharma
The top 10 pharma companies on the 2022 Fortune 500 list
May 27 by Leila HawkinsWe look at the top 10 pharmaceutical companies on the Fortune 500 list this year
Keeping tabs on pharma: UK hails “major step forward” in treating schizophrenia
February 08 by Leila HawkinsUK approves first long-acting new treatment for schizophrenia, Venus Remedies joins coalition to tackle anti-microbial resistance (AMR) and FDA resumes medical device inspections as Covid rates drop
Keeping tabs on Covid-19: AstraZeneca hoping to win US approval for their Covid-19 vaccine and J&J resumes its vaccine roll out in Europe
April 23 by Emily UwemedimoWith global demand for the Covid-19 vaccine still uncertain, two big pharma companies look to enhance their vaccination roll out programs in Europe and the US
Keeping tabs on Covid-19: Johnson & Johnson’s Covid-19 supply delay, Germany pauses its use of AstraZeneca’s vaccine and portable cold carrier launched to help with vaccine roll-out
April 01 by Emily UwemedimoThe European Medicines Agency sought to add clarity to the concerns surrounding AstraZeneca’s Covid-19 vaccine, but Germany has pressed the pause button as a “precaution” despite EMA backing
Keeping tabs on pharma: Johnson & Johnson’s single-dose vaccine is 72 percent effective and the global antibiotics market set to increase in value
February 26 by Emily UwemedimoThe FDA has authorized Johnson & Johnson's Covid-19 vaccine for emergency use, a critical step in bringing a third shot to the US
Philippines FDA to speed up Covid-19 clinical trial approval decisions by 50 per cent
February 18 by Emily UwemedimoJanssen among pharma firms being provided increased transparency of regulatory decisions on clinical trial processes in the Philippines
Keeping tabs on Covid-19: Pharma sector not immune to pandemic’s financial pressures and stakeholders demand decisions of vaccine prices are made public
February 05 by Emily UwemedimoDiscover how the outbreak of coronavirus has caused unprecedented impacts on the pharma industry’s annual budgets
Keeping tabs on Covid-19: Positive results from J&J vaccine, genome scanning platform identifies T cell receptors and new partnership innovates vaccine process
July 31 by Emily UwemedimoFollow Pharma IQ’s weekly coverage on coronavirus to keep up to date with emerging studies, vaccine updates and new technologies battling at the frontlines of the battle to overcome the Covid-19 pande...